HALB (Halberd) Accounts Payable: $0.58 Mil (As of Jul. 2023)


What is Halberd Accounts Payable?

Halberd HALB Accounts Payable is $0.58 Mil as of Jul. 2023.

Halberd's Accounts Payable for the quarter that ended in Jul. 2023 was $0.58 Mil.

Halberd's quarterly Accounts Payable increased from Jul. 2008 ($0.02 Mil) to Jul. 2022 ($0.38 Mil) and increased from Jul. 2022 ($0.38 Mil) to Jul. 2023 ($0.58 Mil).

Halberd's annual Accounts Payable increased from Jul. 2008 ($0.02 Mil) to Jul. 2022 ($0.38 Mil) and increased from Jul. 2022 ($0.38 Mil) to Jul. 2023 ($0.58 Mil).


Halberd Accounts Payable Historical Data

* Premium members only.

The historical data trend for Halberd's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Halberd Accounts Payable Chart

Halberd Annual Data
Trend Jul08 Jul22 Jul23
Accounts Payable
0.02 0.38 0.58

Halberd Semi-Annual Data
Jul08 Jul22 Jul23
Accounts Payable 0.02 0.38 0.58

Halberd Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Frequently Asked Questions Learn more about Accounts Payable →
What does a Accounts Payable of $0.58 Mil mean?
Halberd (HALB) has a Accounts Payable of $0.58 Mil as of Jul. 2023. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Halberd and its competitors.
Is Halberd's Accounts Payable too high?
Halberd's current Accounts Payable is $0.58 Mil.
How does Halberd's Accounts Payable compare to GRI and OCEA?
Halberd's Accounts Payable of $0.58 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accounts Payable for a Biotechnology company?
A good Accounts Payable depends on the Biotechnology industry context. However, Accounts Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accounts Payable mean?
A high Accounts Payable can signal that a stock is expensive relative to its fundamentals. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Halberd and its competitors. Halberd's current Accounts Payable is $0.58 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Halberd stock overvalued right now?
Halberd (HALB) has a current Accounts Payable of $0.58 Mil. The current Accounts Payable is $0.58 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accounts Payable calculated?
Accounts Payable is calculated from a company's financial statements. For Halberd (HALB), the current Accounts Payable is $0.58 Mil as of Jul. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Halberd Business Description

Address P.O. Box 25, Jackson Center, PA, USA, 16133
Halberd Corp is a holding company and acquisition vehicle for established businesses. It is also developing a patented process for disease eradication by removing the pathophysiologic basis of the disease. The company is focused on developing treatments for neurodegenerative diseases, such as PTSD and CTE (Post Traumatic Stress Disorder and Chronic Traumatic Encephalopathy), Alzheimer's Disease, Parkinson's Disease, etc.